CASE REPORT
|
doi:10.20944/preprints202307.0642.v2
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC; metastasis; immunotherapy; complete response; case report; literature review
Online: 8 December 2023 (10:10:13 CET)
REVIEW
|
doi:10.20944/preprints202112.0145.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
oligoprogression; NSCLC; ALK rearrangement
Online: 9 December 2021 (08:36:50 CET)
REVIEW
|
doi:10.20944/preprints202105.0471.v1
Online: 20 May 2021 (10:05:40 CEST)
REVIEW
|
doi:10.20944/preprints202410.1934.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
SBRT; ultra-central; NSCLC; oligometastasis; oligoprogression
Online: 24 October 2024 (14:15:15 CEST)
ARTICLE
|
doi:10.20944/preprints202410.0895.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
cancer; NSCLC; EGFR mutations; TKIs; CRISPR
Online: 11 October 2024 (13:30:15 CEST)
ARTICLE
|
doi:10.20944/preprints202308.1350.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Imidazole; Imidazole derivative; Sirtuins; NSCLC; Epigenetics
Online: 18 August 2023 (09:04:18 CEST)
ARTICLE
|
doi:10.20944/preprints202312.1630.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC; galectin; ELISA; treatment; overall survival; prognosis
Online: 21 December 2023 (09:30:06 CET)
REVIEW
|
doi:10.20944/preprints202308.0499.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
Cytokines; autophagy; NSCLC; therapeutics; IL6; IL17; IL23
Online: 7 August 2023 (10:05:44 CEST)
REVIEW
|
doi:10.20944/preprints202307.0251.v1
Subject:
Medicine And Pharmacology,
Surgery
Keywords:
early-stage; stage I; NSCLC; Lymphadenectomy; Micrometastases
Online: 5 July 2023 (08:40:07 CEST)
REVIEW
|
doi:10.20944/preprints202306.0956.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC,; Immunotherapy; Immune Checkpoint Inhibitors; Special populations
Online: 13 June 2023 (16:01:04 CEST)
ARTICLE
|
doi:10.20944/preprints202306.0356.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
NSCLC; JAC4; DNA repair; radiotherapy; bidirectional effect
Online: 5 June 2023 (16:38:38 CEST)
ARTICLE
|
doi:10.20944/preprints202002.0423.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
ITF2_TCF4; chemotheraoy resistance; NSCLC; HOXD9; Wnt pathway
Online: 28 February 2020 (11:58:28 CET)
REVIEW
|
doi:10.20944/preprints202402.0872.v1
Subject:
Biology And Life Sciences,
Life Sciences
Keywords:
Immunotherapy; Immune checkpoint inhibitors; Rechallenge therapy; Resistance; NSCLC
Online: 16 February 2024 (11:34:11 CET)
BRIEF REPORT
|
doi:10.20944/preprints202306.1358.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Liquid biopsy; PD-L1; plasma cfRNA; immunotherapy; NSCLC
Online: 19 June 2023 (12:57:52 CEST)
ARTICLE
|
doi:10.20944/preprints202306.0313.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Liquid biopsy; EGFR; NSCLC; T790M mutation; NGS; PCR
Online: 5 June 2023 (11:06:11 CEST)
ARTICLE
|
doi:10.20944/preprints202201.0141.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
SAMHD1; NSCLC; breast cancer; ovarian cancer; solid tumors
Online: 11 January 2022 (13:05:00 CET)
ARTICLE
|
doi:10.20944/preprints202008.0222.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Erlotinib; POLA2; DARTS LC-MS/MS; Resistance; NSCLC
Online: 9 August 2020 (21:26:35 CEST)
ARTICLE
|
doi:10.20944/preprints202408.1275.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
lung cancer; Adnab-9; colorectal cancer; NSCLC; SCC; ADENOCARCINOMA
Online: 19 August 2024 (12:18:11 CEST)
REVIEW
|
doi:10.20944/preprints202401.0541.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC; ALK inhibitors; lung cancer; targeted therapy; precision medicine
Online: 8 January 2024 (11:27:23 CET)
ARTICLE
|
doi:10.20944/preprints201808.0043.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
cryptotanshinone; NSCLC; cell cycle arrest; apoptosis; PI3K/Akt/GSK3β
Online: 2 August 2018 (09:05:32 CEST)
REVIEW
|
doi:10.20944/preprints202308.0190.v2
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Savolitinib; MET-TKI; NSCLC; gastric cancer; renal cell carcinoma; pancreatic cancer
Online: 7 August 2023 (10:03:49 CEST)
INTERESTING IMAGES
|
doi:10.20944/preprints202305.1169.v1
Subject:
Medicine And Pharmacology,
Pulmonary And Respiratory Medicine
Keywords:
18F-FDG; PET/CT; SMARCA 4; NSCLC; Dynamic imaging;Efficacy evaluation
Online: 17 May 2023 (02:37:11 CEST)
ARTICLE
|
doi:10.20944/preprints202301.0325.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Immune checkpoint inhibitors; Anti-tumor immunity; Predictive biomarker; Malignant melanoma; NSCLC
Online: 18 January 2023 (08:39:18 CET)
REVIEW
|
doi:10.20944/preprints202111.0504.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
NSCLC 1; KRAS G12C mutation 2; targeted therapy 3; immunotherapy 4
Online: 26 November 2021 (11:34:27 CET)
COMMUNICATION
|
doi:10.20944/preprints202111.0052.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
RNA-based NGS; EGFR mutated NSCLC; acquired resistance; RET-fusion; rebiopsy
Online: 2 November 2021 (22:19:36 CET)
REVIEW
|
doi:10.20944/preprints202410.2445.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
lung cancer; NSCLC; SCLC; genetics; pathways; alterations; biomarkers; diagnosis; therapies; personalized medicine
Online: 30 October 2024 (14:34:52 CET)
ARTICLE
|
doi:10.20944/preprints202308.0522.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
lung cancer; NSCLC; lipidomic analysis; saliva; plasma; feces; LC-ESI-MS/MS
Online: 7 August 2023 (11:49:40 CEST)
REVIEW
|
doi:10.20944/preprints202403.0902.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC; lung cancer; gut microbiota; immunotherapy; immune checkpoint inhibitors
Online: 15 March 2024 (07:33:31 CET)
CASE REPORT
|
doi:10.20944/preprints202307.2129.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
brain metastases; NSCLC; predictive biomarkers for radiotherapy; radiotherapy; prognostic scores; WBRT; BRAF mutation
Online: 31 July 2023 (11:49:37 CEST)
CASE REPORT
|
doi:10.20944/preprints202306.0535.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
brain metastases; NSCLC; predictive biomarkers for radiotherapy; radiotherapy; prognostic scores; WBRT; BRAF mutation
Online: 7 June 2023 (10:37:52 CEST)
ARTICLE
|
doi:10.20944/preprints202208.0208.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Plasma PD-L1; liquid biopsy; cfRNA; immune checkpoint inhibitor; predictive immune biomarker; NSCLC
Online: 11 August 2022 (06:10:34 CEST)
ARTICLE
|
doi:10.20944/preprints201908.0117.v1
Subject:
Biology And Life Sciences,
Anatomy And Physiology
Keywords:
Astragalus polysaccharide, PG2, cisplatin, macrophages, monocytes, M1/M2 polarization, immunotherapy, maintenance therapy,lung cancer, NSCLC
Online: 9 August 2019 (12:13:24 CEST)
REVIEW
|
doi:10.20944/preprints202410.1576.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
anti-EGF antibodies; CIMAvax-EGF; lung cancer; lung cancer vaccine; non-small cell lung cancer (NSCLC)
Online: 21 October 2024 (12:00:49 CEST)
REVIEW
|
doi:10.20944/preprints202307.1242.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Immune checkpoint inhibitors (ICIs); Non–small cell lung cancer (NSCLC); PD-1 , PD-L1; CTLA-4
Online: 19 July 2023 (02:48:47 CEST)
CASE REPORT
|
doi:10.20944/preprints202005.0220.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
checkpoint inhibitors; tuberculosis; non-small cell lung cancer (NSCLC); Anti-PD-1; toxicity management; immunotherapy; pembrolizumab
Online: 13 May 2020 (04:38:50 CEST)
REVIEW
|
doi:10.20944/preprints202409.1475.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Non-small cell lung cancer (NSCLC); Vascular endothelial growth factor (VEGF); VEGF receptors (VEGFRs); Angiogenesis; Biomarker; Tumor angiogenesis
Online: 19 September 2024 (11:16:07 CEST)
ARTICLE
|
doi:10.20944/preprints202309.1488.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC; neoadjuvant therapy; overall survival; locally advanced; lymph nodal downstaging; induction therapy; thoracic surgery; chemotherapy; resectable; multimodal; age
Online: 22 September 2023 (02:57:46 CEST)
REVIEW
|
doi:10.20944/preprints202305.0122.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Non-small cell lung cancer (NSCLC); EGFR; Tyrosine kinase inhibitors (TKIs); Uncommon mutation; Compound mutation; Intracranial activity; Immunotherapy
Online: 3 May 2023 (09:29:08 CEST)
ARTICLE
|
doi:10.20944/preprints202105.0524.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
Hsp70; sandwich ELISA; liquid biopsy; tumor biomarker; exosomes; prediction; response monitoring; non-small cell lung carcinoma (NSCLC); glioblastoma
Online: 21 May 2021 (15:06:37 CEST)
ARTICLE
|
doi:10.20944/preprints202005.0077.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
centromere protein F (CENPF); Estrogen Receptor beta; Lung Adenocarcinoma (LUAD); WGCNA package; non-small cell lung cancer (NSCLC)
Online: 5 May 2020 (12:08:59 CEST)
ARTICLE
|
doi:10.20944/preprints202407.0487.v1
Subject:
Medicine And Pharmacology,
Pulmonary And Respiratory Medicine
Keywords:
Neutrophil to lymphocyte ratio (NLR); Platelets to lymphocite ratio (PLR); Non Small Cell Lung Cancer (NSCLC); molecular mutations; EGFR
Online: 6 July 2024 (03:29:58 CEST)
REVIEW
|
doi:10.20944/preprints202107.0353.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Lung cancer; Adjuvant treatment; Non-small-cell lung carcinoma (NSCLC); Epidermal growth factor receptor (EGFR); Tyrosine kinase inhibitor (TKI)
Online: 15 July 2021 (10:16:30 CEST)
ARTICLE
|
doi:10.20944/preprints202410.0473.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
SATB1; EGFR; NSCLC; AC; LSCC; non-small cell lung carcinoma; lung adenocarcinoma; lung squamous cell carcinoma; epithelial growth factor receptor
Online: 7 October 2024 (12:27:50 CEST)
REVIEW
|
doi:10.20944/preprints202306.1853.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
interleukin-1 beta (IL-1β); immune-checkpoint inhibitors (ICIs); non-small cell lung cancer (NSCLC); programmed death ligand 1 (PD-L1); therapeutic resistance
Online: 27 June 2023 (07:16:09 CEST)
ARTICLE
|
doi:10.20944/preprints202201.0390.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
non-small cell lung cancer (NSCLC); liquid biopsy; cell-free nucleic acid (cfNA); next generation sequencing (NGS); CNA (copy number amplifications); fusions, exon-skipping.
Online: 26 January 2022 (03:21:12 CET)